{
    "data": [
        {
            "id": "69050c20ecb8a70001463624",
            "title": "Oklo Stock Is Falling Friday: What&#39;s Going On?",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\"><strong>Oklo Inc</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/OKLO\" target=\"_blank\">OKLO</a>) shares are trading lower Friday afternoon, continuing a volatile week driven by conflicting catalysts for the nuclear startup. Here’s what investors <a href=\"https://www.benzinga.com/trading-ideas/movers/25/10/48467803/nuclear-stocks-boom-on-camecos-deal-with-trump-administration\" target=\"_blank\">need to know</a>.</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li>OKLO is having a challenging session. <a href=\"https://www.benzinga.com/quote/OKLO\" rel=\"noreferrer noopener\" target=\"_blank\">Check the full analysis here.</a></li>\n</ul><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\"><strong>What To Know:</strong> The stock surged early in the week on sector-wide optimism after news of an $80 billion deal between <strong>Cameco</strong> and the Trump administration to construct new reactors. However, the rally faded as investors re-evaluated Oklo’s “<a href=\"https://www.benzinga.com/trading-ideas/movers/25/10/48440402/oklo-stock-is-falling-today-whats-going-on\" target=\"_blank\">fundamental risks</a>,” including its pre-revenue status.</p><!--/$--><!--$--><p class=\"block core-block\">Adding to the week’s news, Oklo filed a Form S-3 shelf registration with the SEC on Wednesday. This filing allows the company to offer and sell up to <a href=\"https://d18rn0p25nwr6d.cloudfront.net/CIK-0001849056/82d9bb33-7834-463a-9fd4-fe5a6ff09308.pdf\" target=\"_blank\">$3.5 billion</a> in aggregate of various securities, including common stock, preferred stock and debt securities. The registration could provide future financing flexibility, permitting Oklo to sell these securities from time to time.</p><!--/$--><!--$--><p class=\"block core-block\">Analyst ratings have been mixed, with <a href=\"https://www.benzinga.com/quote/OKLO/analyst-ratings\" target=\"_blank\">recent downgrades</a> from B of A Securities and Seaport Global, but new Buy or Overweight initiations from Canaccord Genuity and Barclays. Investors are now looking toward Oklo’s quarterly <a href=\"https://www.benzinga.com/quote/OKLO/earnings\" target=\"_blank\">earnings report</a> on Nov. 11. Analysts are forecasting a loss of 13 cents per share.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Benzinga Edge Rankings:</strong> Reflecting its recent volatility, <a href=\"http://benzinga.grsm.io/register174\" target=\"_blank\">Benzinga Edge</a> stock rankings show OKLO with a high Momentum score of 99.29.</p><!--/$--><!--$--><!--/$--><!--$--><p class=\"block core-block\"><strong>OKLO Price Action:</strong> Oklo shares were down 2.5% at $133.94 at the time of publication on Friday, <a href=\"https://www.benzinga.com/pro/\" rel=\"noreferrer noopener\" target=\"_blank\">according to Benzinga Pro data</a>.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Read Also: <a href=\"https://www.benzinga.com/trading-ideas/movers/25/10/48567021/reddit-shares-are-trading-higher-friday-whats-going-on\" target=\"_blank\">Reddit Shares Are Trading Higher Friday: What’s Going On?</a></strong></p><!--/$--><!--$--><div class=\"sc-gQfuga iaHpuj\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">How To Buy OKLO Stock</h2><!--/$--><!--$--><p class=\"block core-block\">Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. </p><!--/$--><!--$--><p class=\"block core-block\">For example, in Oklo’s case, it is in the Utilities sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.</p><!--/$--><!--$--><p class=\"block core-block\"><em>Image: Shutterstock</em></p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48572186\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/31/Oklo-Inc-.jpeg",
            "link": "https://www.benzinga.com/trading-ideas/movers/25/10/48572186/oklo-stock-is-falling-friday-whats-going-on",
            "pub_date": "2025-11-01 03:21:08",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "690507f0ecb8a70001463386",
            "title": "A Glimpse of Castle Biosciences&#39;s Earnings Potential",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\">Castle Biosciences (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/CSTL\" target=\"_blank\">CSTL</a>) will release its quarterly earnings report on Monday, 2025-11-03. Here's a brief overview for investors ahead of the announcement.</p><!--/$--><!--$--><p class=\"block core-block\">Analysts anticipate Castle Biosciences to report an <strong>earnings per share</strong> (EPS) of $-0.44.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The announcement from Castle Biosciences is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p><!--/$--><!--$--><p class=\"block core-block\">It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p><!--/$--><!--$--><h3 class=\"block core-block\">Past Earnings Performance</h3><!--/$--><!--$--><p class=\"block core-block\">During the last quarter, the company reported an EPS beat by $0.65, leading to a 32.83% increase in the share price on the subsequent day.</p><!--/$--><!--$--><p class=\"block core-block\">Here's a look at Castle Biosciences's past performance and the resulting price change:</p><!--/$--><!--$--><div class=\"sc-eQzVdq kfhAgV\"></div><!--/$--><!--$--><!--/$--><!--$--><div class=\"sc-feVKPA LhjAx core-image flex items-center justify-center\"><span style=\"background:none;border:0;box-sizing:border-box;display:inline-block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:relative;max-width:100%\"><span style=\"background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;padding:0;width:initial;max-width:100%\"><img alt=\"\" aria-hidden=\"true\" src=\"data:image/svg+xml;base64,PHN2ZyB3aWR0aD0iNzAwIiBoZWlnaHQ9IjUwMCIgeG1sbnM9Imh0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnIiB2ZXJzaW9uPSIxLjEiLz4=\" style=\"background:none;border:0;display:block;height:initial;margin:0;max-width:100%;opacity:1;padding:0;width:initial\"/></span><img alt=\"\" decoding=\"async\" loading=\"lazy\" src=\"data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\" style=\"border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain\"/><noscript><img alt=\"\" decoding=\"async\" fetchpriority=\"low\" loading=\"lazy\" sizes=\"(max-width: 800px) 700px, (min-width: 800px) 700px\" src=\"https://www.benzinga.com/files/images/story/2025/1761937392_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=1920\" srcset=\"https://www.benzinga.com/files/images/story/2025/1761937392_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=750 1x, https://www.benzinga.com/files/images/story/2025/1761937392_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=1920 2x\" style=\"border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain\"/></noscript></span></div><!--/$--><!--$--><h3 class=\"block core-block\">Stock Performance</h3><!--/$--><!--$--><p class=\"block core-block\">Shares of Castle Biosciences were trading at $24.21 as of October 30. Over the last 52-week period, shares are down 25.98%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><h3 class=\"block core-block\">Analyst Views on Castle Biosciences</h3><!--/$--><!--$--><p class=\"block core-block\">Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Castle Biosciences.</p><!--/$--><!--$--><p class=\"block core-block\">Castle Biosciences has received a total of 1 ratings from analysts, with the consensus rating as Buy. With an average one-year price target of $37.0, the consensus suggests a potential 52.83% upside.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h3 class=\"block core-block\">Peer Ratings Comparison</h3><!--/$--><!--$--><p class=\"block core-block\">The below comparison of the analyst ratings and average 1-year price targets of Fulgent Genetics, AMN Healthcare Services and InnovAge Holding, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.</p><!--/$--><!--$--><ul class=\"block core-block\">\n<li>Analysts currently favor an Buy trajectory for Fulgent Genetics, with an average 1-year price target of $25.5, suggesting a potential 5.33% upside.</li>\n<li>Analysts currently favor an Outperform trajectory for AMN Healthcare Services, with an average 1-year price target of $21.5, suggesting a potential 11.19% downside.</li>\n<li>Analysts currently favor an Underperform trajectory for InnovAge Holding, with an average 1-year price target of $5.0, suggesting a potential 79.35% downside.</li>\n</ul><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h3 class=\"block core-block\">Comprehensive Peer Analysis Summary</h3><!--/$--><!--$--><p class=\"block core-block\">The peer analysis summary outlines pivotal metrics for Fulgent Genetics, AMN Healthcare Services and InnovAge Holding, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p><!--/$--><!--$--><!--/$--><!--$--><p class=\"block core-block\">Key Takeaway:</p><!--/$--><!--$--><p class=\"block core-block\">Castle Biosciences ranks at the top for Gross Profit and Return on Equity among its peers. It is in the middle for Revenue Growth.</p><!--/$--><!--$--><h3 class=\"block core-block\">Discovering Castle Biosciences: A Closer Look</h3><!--/$--><!--$--><p class=\"block core-block\">Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.</p><!--/$--><!--$--><h3 class=\"block core-block\">Castle Biosciences: Financial Performance Dissected</h3><!--/$--><!--$--><p class=\"block core-block\"><strong>Market Capitalization Analysis:</strong> The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Negative Revenue Trend:</strong> Examining Castle Biosciences's financials over 3 months reveals challenges. As of 30 June, 2025, the company experienced a decline of approximately <strong>-0.94%</strong> in revenue growth, reflecting a decrease in top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>5.25%,</strong> the company showcases strong profitability and effective cost control.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Return on Equity (ROE):</strong> Castle Biosciences's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>1.01%</strong> ROE, the company effectively utilizes shareholder equity capital.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Return on Assets (ROA):</strong> Castle Biosciences's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>0.86%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Debt Management:</strong> Castle Biosciences's debt-to-equity ratio is below the industry average. With a ratio of <b>0.08</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p><!--/$--><!--$--><p class=\"block core-block\"><a href=\"https://www.benzinga.com/quote/CSTL/earnings\" target=\"_blank\"><strong>To track all earnings releases for Castle Biosciences visit their earnings calendar on our site.</strong></a></p><!--/$--><!--$--><p class=\"block core-block\"><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p><!--/$--></div></div>",
            "image": "",
            "link": "https://www.benzinga.com/insights/earnings/25/10/48571556/a-glimpse-of-castle-biosciencess-earnings-potential",
            "pub_date": "2025-11-01 03:03:15",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "690507fcecb8a70001463391",
            "title": "Insights into Adtran&#39;s Upcoming Earnings",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\">Adtran (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/ADTN\" target=\"_blank\">ADTN</a>) is gearing up to announce its quarterly earnings on Monday, 2025-11-03. Here's a quick overview of what investors should know before the release.</p><!--/$--><!--$--><p class=\"block core-block\">Analysts are estimating that Adtran will report an <strong>earnings per share</strong> (EPS) of $0.05.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">Anticipation surrounds Adtran's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p><!--/$--><!--$--><p class=\"block core-block\">New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p><!--/$--><!--$--><h3 class=\"block core-block\">Past Earnings Performance</h3><!--/$--><!--$--><p class=\"block core-block\">During the last quarter, the company reported an EPS beat by $0.02, leading to a 14.57% drop in the share price on the subsequent day.</p><!--/$--><!--$--><p class=\"block core-block\">Here's a look at Adtran's past performance and the resulting price change:</p><!--/$--><!--$--><div class=\"sc-fzzUx jSgJNL\"></div><!--/$--><!--$--><!--/$--><!--$--><div class=\"sc-feVKPA LhjAx core-image flex items-center justify-center\"><span style=\"background:none;border:0;box-sizing:border-box;display:inline-block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:relative;max-width:100%\"><span style=\"background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;padding:0;width:initial;max-width:100%\"><img alt=\"\" aria-hidden=\"true\" src=\"data:image/svg+xml;base64,PHN2ZyB3aWR0aD0iNzAwIiBoZWlnaHQ9IjUwMCIgeG1sbnM9Imh0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnIiB2ZXJzaW9uPSIxLjEiLz4=\" style=\"background:none;border:0;display:block;height:initial;margin:0;max-width:100%;opacity:1;padding:0;width:initial\"/></span><img alt=\"\" decoding=\"async\" loading=\"lazy\" src=\"data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\" style=\"border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain\"/><noscript><img alt=\"\" decoding=\"async\" fetchpriority=\"low\" loading=\"lazy\" sizes=\"(max-width: 800px) 700px, (min-width: 800px) 700px\" src=\"https://www.benzinga.com/files/images/story/2025/1761937405_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=1920\" srcset=\"https://www.benzinga.com/files/images/story/2025/1761937405_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=750 1x, https://www.benzinga.com/files/images/story/2025/1761937405_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=1920 2x\" style=\"border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain\"/></noscript></span></div><!--/$--><!--$--><h3 class=\"block core-block\">Stock Performance</h3><!--/$--><!--$--><p class=\"block core-block\">Shares of Adtran were trading at $10.54 as of October 30. Over the last 52-week period, shares are up 67.58%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><h3 class=\"block core-block\">Analysts' Take on Adtran</h3><!--/$--><!--$--><p class=\"block core-block\">Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Adtran.</p><!--/$--><!--$--><p class=\"block core-block\">Analysts have given Adtran a total of 1 ratings, with the consensus rating being Buy. The average one-year price target is $16.0, indicating a potential 51.8% upside.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h3 class=\"block core-block\">Peer Ratings Comparison</h3><!--/$--><!--$--><p class=\"block core-block\">In this analysis, we delve into the analyst ratings and average 1-year price targets of Gilat Satellite Networks, Netgear and Ribbon Communications, three key industry players, offering insights into their relative performance expectations and market positioning.</p><!--/$--><!--$--><ul class=\"block core-block\">\n<li>Analysts currently favor an Buy trajectory for Gilat Satellite Networks, with an average 1-year price target of $11.0, suggesting a potential 4.36% upside.</li>\n<li>Analysts currently favor an Buy trajectory for Netgear, with an average 1-year price target of $38.0, suggesting a potential 260.53% upside.</li>\n<li>Analysts currently favor an Buy trajectory for Ribbon Communications, with an average 1-year price target of $6.0, suggesting a potential 43.07% downside.</li>\n</ul><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h3 class=\"block core-block\">Peer Analysis Summary</h3><!--/$--><!--$--><p class=\"block core-block\">The peer analysis summary presents essential metrics for Gilat Satellite Networks, Netgear and Ribbon Communications, unveiling their respective standings within the industry and providing valuable insights into their market positions and comparative performance.</p><!--/$--><!--$--><!--/$--><!--$--><p class=\"block core-block\">Key Takeaway:</p><!--/$--><!--$--><p class=\"block core-block\">Adtran ranks at the bottom for Revenue Growth among its peers. It also ranks at the bottom for Gross Profit. However, it ranks at the top for Consensus rating. Adtran is at the bottom for Return on Equity compared to its peers.</p><!--/$--><!--$--><h3 class=\"block core-block\">Get to Know Adtran Better</h3><!--/$--><!--$--><p class=\"block core-block\">Adtran Holdings Inc is a provider of networking and communications platforms, software, and services focused on the broadband access market. It operates under two reportable segments: Network Solutions, which includes hardware and software products that enable a digital future that supports the company's Subscriber, Access &amp; Aggregation, and Optical Networking Solutions; and Services &amp; Support Segment which includes network design, implementation, maintenance and cloud-hosted services supporting the company's Subscriber, Access &amp; Aggregation, and Optical Networking Solutions.</p><!--/$--><!--$--><h3 class=\"block core-block\">Adtran's Financial Performance</h3><!--/$--><!--$--><p class=\"block core-block\"><strong>Market Capitalization Perspectives:</strong> The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Positive Revenue Trend:</strong> Examining Adtran's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>17.29%</strong> as of 30 June, 2025, showcasing a substantial increase in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Information Technology sector.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Net Margin:</strong> Adtran's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of <strong>-7.75%,</strong> the company may encounter challenges in effective cost control.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Return on Equity (ROE):</strong> Adtran's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of <strong>-9.43%,</strong> the company may face hurdles in achieving optimal financial performance.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Return on Assets (ROA):</strong> Adtran's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of <strong>-1.61%,</strong> the company may face hurdles in achieving optimal financial returns.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Debt Management:</strong> With a high debt-to-equity ratio of <strong>1.29</strong>, Adtran faces challenges in effectively managing its debt levels, indicating potential financial strain.</p><!--/$--><!--$--><p class=\"block core-block\"><a href=\"https://www.benzinga.com/quote/ADTN/earnings\" target=\"_blank\"><strong>To track all earnings releases for Adtran visit their earnings calendar on our site.</strong></a></p><!--/$--><!--$--><p class=\"block core-block\"><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p><!--/$--></div></div>",
            "image": "",
            "link": "https://www.benzinga.com/insights/earnings/25/10/48571567/insights-into-adtrans-upcoming-earnings",
            "pub_date": "2025-11-01 03:03:28",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "6904f9d8ecb8a70001462c70",
            "title": "Upwork Earnings Preview",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\"><strong>Upwork</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/UPWK\" target=\"_blank\">UPWK</a>) is set to give its latest quarterly earnings report on Monday, 2025-11-03. Here's what investors need to know before the announcement.</p><!--/$--><!--$--><p class=\"block core-block\">Analysts estimate that Upwork will report an <strong>earnings per share</strong> (EPS) of $0.27. </p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The market awaits Upwork's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p><!--/$--><!--$--><p class=\"block core-block\">It's important for new investors to understand that guidance can be a significant driver of stock prices.</p><!--/$--><!--$--><h3 class=\"block core-block\">Earnings Track Record</h3><!--/$--><!--$--><p class=\"block core-block\">The company's EPS beat by $0.10 in the last quarter, leading to a 13.64% increase in the share price on the following day.</p><!--/$--><!--$--><p class=\"block core-block\">Here's a look at Upwork's past performance and the resulting price change:</p><!--/$--><!--$--><div class=\"sc-fzzUx jSgJNL\"></div><!--/$--><!--$--><!--/$--><!--$--><div class=\"sc-feVKPA LhjAx core-image flex items-center justify-center\"><span style=\"background:none;border:0;box-sizing:border-box;display:inline-block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:relative;max-width:100%\"><span style=\"background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;padding:0;width:initial;max-width:100%\"><img alt=\"\" aria-hidden=\"true\" src=\"data:image/svg+xml;base64,PHN2ZyB3aWR0aD0iNzAwIiBoZWlnaHQ9IjUwMCIgeG1sbnM9Imh0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnIiB2ZXJzaW9uPSIxLjEiLz4=\" style=\"background:none;border:0;display:block;height:initial;margin:0;max-width:100%;opacity:1;padding:0;width:initial\"/></span><img alt=\"\" decoding=\"async\" loading=\"lazy\" src=\"data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\" style=\"border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain\"/><noscript><img alt=\"\" decoding=\"async\" fetchpriority=\"low\" loading=\"lazy\" sizes=\"(max-width: 800px) 700px, (min-width: 800px) 700px\" src=\"https://www.benzinga.com/files/images/story/2025/1761933785_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=1920\" srcset=\"https://www.benzinga.com/files/images/story/2025/1761933785_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=750 1x, https://www.benzinga.com/files/images/story/2025/1761933785_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=1920 2x\" style=\"border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain\"/></noscript></span></div><!--/$--><!--$--><h3 class=\"block core-block\">Tracking Upwork's Stock Performance</h3><!--/$--><!--$--><p class=\"block core-block\">Shares of Upwork were trading at $16.31 as of October 30. Over the last 52-week period, shares are up 19.41%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p><!--/$--><!--$--><p class=\"block core-block\"><a href=\"https://www.benzinga.com/quote/UPWK/earnings\" target=\"_blank\"><strong>To track all earnings releases for Upwork visit their earnings calendar on our site.</strong></a></p><!--/$--><!--$--><p class=\"block core-block\"><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p><!--/$--></div></div>",
            "image": "",
            "link": "https://www.benzinga.com/insights/earnings/25/10/48569749/upwork-earnings-preview",
            "pub_date": "2025-11-01 02:03:08",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "6904fc74ecb8a70001462dd4",
            "title": "FBI Foils ISIS-Inspired Plot To Attack Michigan Over Halloween Weekend",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\">On Friday, the FBI successfully averted a potential terrorist attack planned for Halloween weekend in Michigan. The plot, inspired by ISIS, was uncovered through online chatrooms where suspects discussed executing a violent attack, according to <a href=\"https://www.benzinga.com/news/politics/25/09/47729209/fbi-director-kash-patel-bought-2-stocks-in-2025-ones-already-a-meme-favorite\" target=\"_blank\">FBI Director<strong> Kash Patel</strong>.</a></p><!--/$--><!--$--><p class=\"block core-block\">CNN <a href=\"https://www.cnn.com/2025/10/31/us/michigan-potential-terrorist-attack-averted-fbi\" target=\"_blank\">reports</a> that multiple individuals were arrested as the FBI, operating from its Detroit field office, executed search warrants and subpoenas for phones, computers and other materials. </p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">“This morning the FBI thwarted a potential terrorist attack and arrested multiple subjects in Michigan who were allegedly plotting a violent attack over Halloween weekend,” Patel said.</p><!--/$--><!--$--><!--/$--><!--$--><p class=\"block core-block\"><strong>Also Read: <a href=\"https://www.benzinga.com/crypto/cryptocurrency/25/10/48396793/trump-backed-world-liberty-financial-token-rallies-12-leaves-bitcoin-ethereum-trailing-in-the-dust\" target=\"_blank\">Trump-Backed World Liberty Financial Token Rallies 12%, Leaves Bitcoin, Ethereum Trailing In The Dust</a></strong></p><!--/$--><!--$--><h2 class=\"wp-block-heading\"><strong>How The FBI Prevented A Halloween Attack</strong></h2><!--/$--><!--$--><p class=\"block core-block\">The FBI’s intervention was prompted by the suspects’ activities, which included visiting a shooting range with AK-47s and practicing high-speed reloads. A reference to “pumpkin day,” believed to be a code for Halloween, was reportedly picked up during their discussions. This led the FBI to act swiftly to prevent any potential threat.</p><!--/$--><!--$--><div class=\"sc-ewfYpr ctXQJP\"></div><!--/$--><!--$--><p class=\"block core-block\">According to<strong> John Miller</strong>, CNN's chief law enforcement and intelligence analyst, the investigation began months ago and involved individuals communicating online, both domestically and internationally. An undercover FBI agent was introduced into the chatroom early in the discussions.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\"><strong>What Motivated This Group’s Violent Plot?</strong></h2><!--/$--><!--$--><p class=\"block core-block\">The suspects were allegedly motivated by ISIS and had been discussing various options for a potential attack in the U.S. The specifics of their plan, including the target and timing, were unclear, but their activities at the shooting range raised significant concerns.</p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\">As reported by CNN, Michigan Gov. <strong>Gretchen Whitmer</strong> expressed gratitude for the quick response by the FBI and Michigan State Police, stating, “I am grateful for the swift action of the FBI and MSP protecting Michiganders.”</p><!--/$--><!--$--><h2 class=\"wp-block-heading\"><strong>The Growing Threat Of Online Radicalization</strong></h2><!--/$--><!--$--><p class=\"block core-block\">This case highlights the ongoing threat of online radicalization, where individuals are influenced by extremist ideologies through digital platforms. The FBI’s proactive measures demonstrate the importance of monitoring such communications to prevent potential attacks.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The Dearborn Police Department assured residents that there is no current threat to the community, emphasizing the effectiveness of the coordinated law enforcement response.</p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48570086\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><a href=\"https://www.benzinga.com/markets/tech/25/10/48396808/ford-is-pausing-the-production-of-the-best-selling-ev-pickup-in-us-here-is-what-the-company-said-about-the-f-150-lightning\" target=\"_blank\"><strong>Ford Is Pausing The Production Of The Best-Selling EV Pickup In US: Here Is What The Company Said About The F-150 Lightning</strong></a></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em>Photo: Matt Ragen/Shutterstock</em></p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/31/A-Block-Of-Tidy-And-Well-maintained-Hous.jpeg",
            "link": "https://www.benzinga.com/news/politics/25/10/48570086/fbi-foils-isis-inspired-plot-to-attack-michigan-over-halloween-weekend",
            "pub_date": "2025-11-01 02:14:16",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        }
    ]
}